Since the development of the World Health Organization (WHO) Air Quality Guidelines for Europe, a large number of epidemiologic studies have been published documenting effects of major air pollutants on health at concentrations below existing guidelines and standards. In this review, recent studies are discussed that permit some evaluation of short-term health effects observed at exposure levels lower than the current WHO Guidelines or U.S. Environmental Protection Agency (U.S. EPA) standards. Some studies have been conducted at concentration levels that never exceeded existing guidelines or standards. Other studies have been conducted at exposure levels sometimes exceeding current guidelines or standards. The published analyses of several of these studies permit evaluation of low-level health effects either because analyses were restricted to levels not exceeding the guidelines or graphic analyses were reported suggesting effects at these low levels. For ambient ozone, effects on lung function of subjects exercising outdoors have now been documented at 1-hr maximum levels not exceeding 120 pg/m3, i.e., half the current U.S. EPA standard. One study even suggests that such effects occur at levels below 100 pg/m3. Several studies are now available documenting effects of particulate air pollution on health in the virtual absence of SOL. Effects on mortality and hospital admissions for asthma have been documented at levels not exceeding 100 pg/m3, expressed as 24-hr average inhalable particles PM10 concentration. Effects on lung function, acute respiratory symptoms, and medication use have been found at 24-hr average PM10 levels not exceeding 115 pg/m3. When the WHO Air Quality Guidelines and the U.S. EPA standard for PM10 were developed, there were no studies available on health effects of PM10. In this review, we include nine studies documenting health effects of measured PM1 0 at low levels of exposure, indicating that there is now an entirely new epidemiologic database that can be evaluated in the process of revising current guidelines and standards. The low levels of exposure at which effects on health were seen underscore the urgent need for such reevaluations. -Environ Health Perspect 1 03(Suppl 2): 3-13 (1995) 
Introduction
Air quality guidelines and standards for the major air pollutants ozone, sulfur doxide, nitrogen dioxide, and suspended particulate matter are based on evidence from controlled animal exposure and the evaluation for NO2 is based mostly on animal and human experiments and to some extent on epidemiologic studies of indoor NO2 exposure. The U.S. Environmental Protection Agency (U.S. EPA) Air Quality Standards for ozone and particulate matter in air are also clearly influenced by results of epidemiologic studies (2, 3) . Epidemiologic studies are particularly important in defining minimum concentrations at which adverse effects on health are detectable. Nevertheless, because actual exposures are always to mixtures of pollutants, epidemiologic studies may not be able to explicitly define the causal agent in the mix of air pollutants. The composition of these mixtures varies in time and space, so that the relationship between measured concentrations of "indicator components" and health effects found in epidemiologic studies may also vary in time and space. This calls for critical appraisal of new research findings, especially those obtained in studies conducted exclusively or mostly at concentration levels below current guidelines. The purpose of this paper is to review epidemiologic studies published after the publication of the WHO Air Quality Guidelines for Europe in 1987, focusing on epidemiologic studies conducted at low levels of the aforementioned major ambient air pollution components. We will also restrict ourselves to investigations of effects of shortterm changes in air pollution because we feel that a discussion of effects of long-term exposure requires a different approach with regard to treatment of potential confounders and other issues, which would extend both the scope and the length of this discussion beyond a reasonable length.
In the following sections, we will first give an admittedly somewhat arbitrary definition of "low levels" of air pollution.
Then we will identify epidemiologic studies published after 1986 that provide information on health effects at these low concentration levels. We will briefly discuss the results of these studies, asking to what extent the findings suggest that adverse health effects occur at low levels of ambient Environmental Health Perspectives air pollution. The validity of the study results will be discussed with respect to exposure assessment, treatment of timevarying potential confounders, and statistical treatment of the data.
Short-term changes in air pollution concentrations have typically been associated with changes in mortality, hospital or emergency room admissions, incidence, duration or exacerbations of respiratory and other symptoms, and changes in lung function indices. We will evaluate studies looking at these effects, in an attempt to establish whether there is coherence in observed effects (4) .
Ozone
For ozone, the WHO Air Quality Guidelines specify that effects on human health such as pulmonary function changes and increased respiratory symptom reporting can be expected in exercising subjects at 1-hr average concentrations exceeding 160 to 200 /m3. A 1-hr guideline in the range of 150 to 200 /m was suggested (1) . The current U.S. EPA standard is 240 pg/mi3 (2) . We will therefore evaluate studies conducted at 1-hr concentrations not exceeding 240 /im3.
Mortality
For ozone, no studies were identified that permit analysis of effects of low concentrations of ozone or total photochemical oxidants on mortality. A recent analysis by Kinney and Ozkaynak (5) suggested that in Los Angeles, daily mortality is associated with photochemical oxidants, but concentrations of ozone frequently exceeded 240 pg/M3 in the observation period (1970) (1971) (1972) (1973) (1974) (1975) (1976) (1977) (1978) (1979) , and the authors did not attempt to censor or otherwise analyze the data to investigate whether effects persisted at low levels of exposure.
Hospital Admissions
Ponka studied asthma admissions in Helsinki, Finland, over a 3-year period (6) . Ozone concentrations were low and ranged from 0 to 90 pg/m3 only. Other pollutants were low also, with the exception of total suspended particulate matter (TSP), which ranged from 6 ml/sec/pg/m3. The coefficient for PEF decreased to -2.0 ml/sec/pg/m3 after exclusion of concentrations over 120 pg/mi3.
In another summer camp study, Spektor et al. (11) found results essentially the same as those obtained earlier (10) . Maximum 1-hr ozone concentrations reached 300 pg/m3, but the results of the regression analysis remained unchanged when ozone concentrations over 240 pg/m3
were excluded from the analysis.. In this study, a significant relationship also was found between lung function measured in the morning and the maximum 1-hr peak ozone concentration of the previous day, suggesting some persistence of the effect.
Berry et al. (12) studied children and counselors in two summer camps. Cough was reported twice as frequently, and eye irritation about one-and-a-half times as frequently on days with 1-hr maximum ozone concentrations in the range of 160 to 240 pg/m3, compared to days with ozone concentrations lower than 160 pg/mi3. Numbers were small, however, and none of these differences reached statistical significance.
Thurston et al. (13) (1-hr maximum) during the observation period. PEF in children and adults was related to ozone concentrations; and for children, a mean coefficient of-1.0 ml/sec/pg/m3 was estimated, with larger effects seen among the asthmatics. The subjects in this study were not outdoors as much, and were not physically active as much as in the summer camp studies, which could explain the smaller mean coefficient. In addition to the lung function effects, a 30% increase in allergic or irritant symptoms (eye irritation or runny nose) was seen when the 8-hr maximum ozone concentration on the previous day was over 110 pg/n3, as opposed to below 110 pg/m3. Hoek et al. (16, 17) studied five hundred thirty-three 6 Table 1 summarizes the results of the studies on ozone that were discussed in this section. Studies of the association of ozone with increased mortality at levels below 240 pg/m3 have not been performed. There is some evidence that at concentrations lower than 240 pg/mr3, hospital admissions for asthma and other respiratory conditions are increased.
A fairly large number of recent studies document that changes in lung function occur at ozone levels sometimes well below 3 240 pg/m . Nine studies were identified that were entirely conducted at ozone 1-hr maximum concentrations below 240 pg/m3 (10, (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . In three studies, ozone concentrations never even exceeded 160 pg/mr3 (13, 14, 22) . In one of the latter studies (13), no effect of ozone on lung function of asthmatic children was found, but the other two documented statistically significant effects even at these low levels of exposure. Some studies have reported analyses restricted to ozone concentrations below certain cutoff points. Even at concentrations lower than 160 (19) or 120 (10, 21) pg/M3, significant effects of ozone on lung function were seen in exercising subjects. These recent studies extend the range of ozone concentrations found to be associated with lung function changes to levels well below 240 pg/mr3 and also to levels well below the 150 to 200 pg/mr3 Table 1 . Summary of studies relating hourly ozone concentrations of less than 240 pg/M3 with specific effects on human health. Concentration  <100  <240  < 240  <240  <240  <240  <240  <240  <200  <200  <160  <160  <160  <160 In experimental studies, the lowest level at which significant effects of ozone on lung function of exercising subjects has been reported is 160 pg/mi, for a multihour exposure (23) . The results of recent epidemiologic studies suggest that at lower levels, effects on lung function are still observable.
Category of health effects

Particles and Sulfur Dioxide
Sulfur dioxide and particulate matter were evaluated jointly in the WHO Air Quality Guidelines on the basis of the observation that they usually occur together, representing a complex mixture dominated by products of fossil fuel combustion (1). The discussion of short-term effects led to the evaluation that excess mortality could be expected to occur at 24-hr levels of SO2 and black smoke both exceeding 500 pg/m3. Likewise, excess morbidity was suggested to occur at SO2 and black smoke levels both exceeding 250 pg/mi3, and temporary decrements in lung function were suggested to occur at levels of TSP exceeding 180 pg/m3, in the presence of elevated concentrations of SO2 (exact levels not specified). Although at the time no studies relating health effects to inhalable particles (PM 10) had been published, it was suggested that 180 pg/mi3 of TSP would be equivalent to 110 pg/mi3 of PM10. Taking into account a margin of protection of about As many recent studies have emphasized that particles may exert adverse effects on health in the absence of high levels of SO2, studies on particles will be discussed first, and studies on SO2 afterward.
Particles Mortality
Several recent studies have addressed the relationship between particulate air pollution and daily mortality at low levels of exposure (24) (25) (26) (27) (28) (29) . Schwartz and Marcus reanalyzed mortality data from London (24) for the winters of 1958 to 1972. In a graphic analysis, they found no evidence for a threshold in the relationship between black smoke and total daily mortality, down to the lowest levels of 20 pg/m3. No interaction between black smoke and SO2 was found, and after adjustment for weather variables and SO2, the effect of smoke remained significant, whereas there was no independent effect of So2 after adjustment for black smoke. The graphic analysis suggesting effects at very low levels was not supported by a specific statistical analysis using censored data, so that it remains unclear what the lowest level of black smoke was below which significant relationships between air pollution and daily mortality could be found. Schwartz (25) to be related to TSP. There was no interaction with SO2, and the effect of TSP was independent of SO . The estimated effects were larger for respiratory and cardiovascular deaths than for other diagnoses, and they were also larger for subjects over 65 years of age than for younger subjects. A graphic analysis suggested that the effect was already detectable at levels below 100 pg/mr3, but no attempt was made to do an analysis with data censored to below certain cutoff points for TSP.
The same authors have also published a very similar analysis of mortality data from Steubenville, Ohio (28) . Again, a graphic analysis suggested effects of TSP on mortality at levels below 100 pg/mi3; but no censoring was applied to the data that would permit identification of a threshold level below which no significant relationship between mortality and TSP exists. Dockery at al. (29) Table 2 summarizes the results of the studies on particles that were discussed in this section. These studies indicate that increases in daily mortality have been found in a situation where measured PM10 concentrations never exceeded 100 pg/mi3 (29) , in a situation where TSP concentrations were censored to below 137 pg/m3 (25) , in three situations where a graphic analysis suggested that effects on mortality were present at levels below 100 pg/m of either PM1O (26) or TSP (27, 28) . A reanalysis of data from London further suggested that daily mortality was related to black smoke without evidence of a threshold at levels down to 20 pg/mi3 (24).
Hospital admissions for respiratory disorders were found to be related to low concentrations of particles in five studies. Most convincing are the studies from Seattle (34), where measured PM10 levels never exceeded 103 pg/mi3 and Birmingham, England (35) , where the weekly average black smoke concentration never exceeded 60 pg/m3. Studies from Barcelona have documented effects at black smoke levels censored to below 150 pg/m3 (32, 33) , and a study from Germany suggested effects on hospital and pediatrician croup visits at TSP levels below 100 pg/mi3 by graphic analysis (30) .
Effects of particulate pollution on acute respiratory symptoms, lung function, and school absenteeism have been found in several recent studies. Some of these were conducted entirely at concentration levels: black smoke < 120 rg/m3 (42) (43) (44) , black smoke <25 pg/m (37), PM1O < 130 pg/m3 (45) . Other studies have employed censoring in the analysis of the data: to below 150 pg/mi3 PM10 (40, 41) or <115 pg/m3 (39) . One study (38) suggested effects on acute respiratory symptoms at TSP levels below 100 pg/m by graphic analysis.
The variety of particulate air pollution measures employed in these studies makes evaluation in terms of one single indicator somewhat problematic. Relationships between the three primary indicators PM10, TSP, and black smoke have been suggested (46) as PM10 BS and PM 10 -TSP x 0.5 5. A proportionality between PM1O and PM2.5 of 0.6 was suggested. However, such relationships may vary from place to place and with time, (45) depending on the contribution of local sources. Nevertheless, on the basis of these relationships the data summarized in Table  2 Lipfert and Hammerstrom (50) analyzed hospital admission data obtained over a 6-year period in southern Ontario, Canada. Respiratory admissions were found to be related to SO2 and ozone, at concentrations that were said to be "generally within U.S. ambient standards," but otherwise unspecified. Consequently, this study cannot be used to make further quantitative inferences.
The studies conducted by Sunyer et al. in Barcelona (32, 33) and Diaz 81 pg/in, and NO2 concentrations were all below 95 pg/m3 as 24-hr averages. To take collinearity of some of the variables and autocorrelation properly into account, data were analyzed by a novel "neural network" approach. The results suggested that PEF decreased when either SO or NO exceeded 40 pg/m3. No data on other pollutants potentially covarying with SO2 and/or NO2 were given. Table 3 summarizes the results of the studies on SO discussed in this section. The evidence ?rom these studies on lowlevel effects of SO2 is less abundant and strong than from studies on ozone and particles. In the mortality study by Mackenbach et al. (47) , no adjustment could be made for particulate air pollution, and the strategy followed to aggressively adjust for weather variables seems unbalanced. Adjustment for potential particle effects was absent from the hospital admission study by Bates et al. (49) as well. An independent effect of low SO concentrations was found by Sunyer et Z.
in Barcelona (32, 33) . However, the authors themselves comment that the measure of particulate matter they used (black smoke) was poorly related to TSP, especially in summer; and it remains unclear to what extent adjustment for potential particle effects was sufficient in their data. Adjustment for potential confounding by particles was done in none of the cited studies looking at lung function and symptom effects. Although some of these studies suggested effects to occur at low to very low levels of SO, the conclusions with regard to SO wll have to remain tentative in light othe generally stronger evidence of effects of particles that are independent of effects of the gaseous components discussed in this section. Virtually no studies have evaluated independent effects of low levels of NO2 in the past few years.
Discussion
In the last 6 years, many epidemiologic studies have been reported that suggest that daily variations in exposure to the major air pollution components ozone, particulate matter, and SO2 are associated with health effects ranging from increased mortality and hospital admissions to subtle changes in lung function at low to very low concentrations. Indeed, several studies have suggested that for some of these effects, it is difficult to establish any threshold at all. Before accepting the potentially large public health implications of these recent findings, the validity of the study results needs to be discussed with respect to exposure assessment, treatment of time-varying potential confounders, and statistical treatment of the data. Rather than trying to summarize the often extensive discussions on these topics contained in the original papers, we will point out some common strengths and weaknesses in the studies discussed in the previous sections. Exposure Assessment The studies discussed in this article have in common that they focus on time-varying exposures and health effects. Ideally, one would like to know the temporal development of personal exposure for all subjects studied. In practice, this has not been feasible in the studies reviewed here. The best exposure assessment was probably made in some of the investigations in which effects of ozone on subjects exercising outdoors were studied (9) (10) (11) (12) (13) (18) (19) (20) (21) (22) . By focusing on subjects exercising outdoors, complications (54) . This concern is further increased by the poor correlation seen between personal exposure measurements and ambient concentrations in some studies (55) . However, most of these personal monitoring studies were cross-sectional in design, and there is virtually no empirical data on the correlation between personal exposure measurements and ambient concentrations as they develop over time. In one study, indoor particle and NO2 concentrations were shown to follow ambient concentrations closely when an air pollution episode occurred, regardless of the presence of indoor sources of these pollutants (56 Gaussian in their distribution, and concern has been raised regarding the appropriate transformations of the data and specific analytic methods. A related issue has been concern for methods for removing seasonal or other long-wave length patterns in the data before evaluating short-term effects. An important principle to consider is that statistics is only a tool that allows us to model reality. All statistical techniques provide approximations of the true associations. The validity of the estimates depends on how well the real data fit the assumptions of the statistical method. Thus it is wrong to suggest that a specific statistical method provides the "right" estimate of association. In fact, a result that is sensitive to the statistical method being used should be viewed with some skepticism; for example, air pollution associations should be robust to the analytic methods used. This is the case for the health end points discussed here. New analysis techniques such as "neural network" methods (53) need to be considered in the context of more traditional methods of analysis for this reason.
Public Health Implications
The health effects found to be associated with daily variations in the concentration of common air pollutants vary from changes in daily mortality to small, reversible changes in lung function. For particles especially, the body of evidence suggests that effects on mortality, hospital admissions, exacerbation of respiratory symptoms, and lung function all occur at comparable, low levels of exposure. Daily counts of mortality and hospital admissions for COPD or asthma are low, so the number of subjects affected by air pollution on any given day is low as well, compared to the size of the population. In contrast, transient effects on lung function may be observed in the majority of the population, and symptom exacerbation may be detected in asthmatics and COPD patients, who may comprise 5 to 10% of the population. and daily mortality are from a public health point of view. The effects on mortality tend to be greater among the elderly, although they are not restricted to the oldest age categories. If daily variations of particulate matter at a low level lead to some "harvesting" effect implying that terminally ill subjects die a few days or weeks earlier than they would have, the public health importance is not as great as when subjects in all age classes and in various states of health are affected. Unfortunately, little is known about the subjects making up the slight excesses in daily mortality associated with air pollution. We do know that at much higher levels, such as those observed in the London smog episode of 1952, some subjects suddenly died on the streets or at work (57) . There is a need to gain more insight into the number of days or years of lost life associated with particulate-matter air pollution, so that the public health implications of these associations can be assessed more fully. In this respect, a recent report from the United States (58) offers intriguing observations. In a follow-up study extending over a 16-year period, low levels of particulate-matter pollution were found to be associated with mortality independent of smoking, occupational exposure, body mass index, age, sex, and education. Yearly average inhalable particulate matter levels (measured as either PM15 or PM10 in the study) ranged from 18 to 47 pg/mi3 with little trend over time, and the relative risk, comparing the most polluted city with the least polluted city, was 1.26. These new data suggest that the associations found in the daily time series studies may imply a significant loss of life expectancy.
Quantitatively, the relationships between daily variations in particulate-matter air pollution and mortality have been expressed in several papers as percentage increase in mortality associated with a certain increase in PM pollution. The magnitude of the increase has been estimated to range from 4 to 7% per 100 pg/m3 TSP (25, 27, 28) and 16% per 100 pg/m3 PM1O (26, 29) . All of these were studies conducted in the United States, and when we take a conversion factor of 0.55 (PM1O/TSP, cf. above) into account, the TSP coefficients translate into estimated PM10 effects of 7 to 13% per 100 pg/m3. The consistency of these effect estimates is high.
For hospital admissions, effects have been estimated at a 24% increase of COPD admissions per 100 pg/m3 in Barcelona (32, 33) , and a 40% increase of asthma admissions per 100 pg/m3 PM1O in Seattle (34) . There are no data to make a reliable conversion of black smoke into PM10 for Barcelona, but if the 1:1 relationship mentioned earlier were valid there as well, the consistency of the effect estimates from these two separate studies is again high.
Effects of PM1O on peak flow of panels of children were reported in five recent papers (39, 40, 42, 44, 45) . Estimated effects ranged from -40 to -110 ml/sec peak flow change per 100 pg/m3 PM1O-again a remarkable consistency over five independent study populations. Such changes represent a mean change in peak flow on the order of 2 to 4% per 100 pg/m3 PM10, which in itself is not large; but especially in panels of asthmatic children, these changes have been found to be accompanied by significant increases in acute respiratory symptoms and/or medication use (39, 40, 42) .
Quantitative exposure-response relationships for ozone are mostly available for effects on short-term changes in lung function, notably, peak flow (10,11,15,17-19, 21,22) . The estimated coefficients range from -100 ml/sec per 100 pg/mi3 of ozone 3 to -460 ml/sec per 100 pg/m . The higher coefficients were found in studies among exercising adults. These coefficients represent seemingly larger effects of ozone than of particles on lung function, of a 100 pg/m3 change. However, there is less evidence of effects of ozone on acute symptoms and medication use
Conclusions
Since the development of the WHO Air Quality Guidelines for Europe, a large number of epidemiologic studies have been published documenting effects of major air pollutants on health at concentrations below existing guidelines and standards.
For ambient ozone, effects on lung function of subjects exercising outdoors have been documented at 1-hr maximum levels not exceeding 120 pg/m3, i.e., half the current U.S. EPA standard.
Several studies are now available documenting effects of particulate air pollution on health in the virtual absence of SO2. Effects on mortality and hospital admissions for asthma have been documented at levels not exceeding 100 pg/mi3, expressed as 24-hr average PM10 concentration. Effects on lung function, acute respiratory symptoms, and medication use have been found at 24-hr average PM10 levels not exceeding 115 pg/m . When the WHO Air Quality Guidelines and the U.S. EPA standard for PM10 were developed, there were no studies available on health effects of PM10. In this review, we have included nine studies documenting health effects of measured PM10 at low levels of exposure, indicating that there is now an entirely new epidemiologic database that can be evaluated in the process of revising current guidelines and standards. The low levels of exposure at which effects on health were seen underscore the urgent need for such reevaluations.
